John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Eversource Energy
ES
$26.4B
| $12.2M | 0.04% |
+138,636
| New | +$11.9M |
|
527
Dover
DOV
$27.2B
| $12.2M | 0.04% |
77,792
+66,590
| +594% | +$10.9M |
|
528
O-I Glass
OI
$1.1B
| $12.2M | 0.04% |
923,574
+32,118
| +4% | +$419K |
|
529
Harmony Gold Mining
HMY
$14.7B
| $12.2M | 0.04% |
2,419,860
+1,487,490
| +160% | +$6.36M |
|
|
SCRM
530
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $12.2M | 0.04% |
+1,250,000
| New | +$12.1M |
|
|
NVO
531
Novo Nordisk
NVO
$207B
| $12.1M | 0.04% |
217,566
-453,564
| -68% | -$23.3M |
|
532
Alnylam Pharmaceuticals
ALNY
$31.6B
| $12.1M | 0.04% |
+73,949
| New | +$11.3M |
|
533
Scorpio Tankers
STNG
$3.93B
| $12.1M | 0.04% |
564,591
+382,503
| +210% | +$6.12M |
|
534
PUT
Southern Company
SO
$102B
| $12.1M | 0.04% |
166,300
+149,800
| +908% | +$10.1M |
|
|
APTS
535
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $12M | 0.04% |
483,000
-68,901
| -12% | -$1.49M |
|
536
Stryker
SYK
$126B
| $12M | 0.04% |
44,919
-31,863
| -41% | -$8.25M |
|
537
Curtiss-Wright
CW
$23.5B
| $11.9M | 0.04% |
79,452
+64,285
| +424% | +$9.15M |
|
|
LAC
538
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $11.9M | 0.04% |
309,006
+118,800
| +62% | +$3.38M |
|
539
Texas Capital Bancshares
TCBI
$4.27B
| $11.9M | 0.04% |
207,321
-115,545
| -36% | -$7.38M |
|
540
IAMGOLD
IAG
$12.1B
| $11.9M | 0.04% |
3,409,751
+2,337,039
| +218% | +$7M |
|
541
GoPro
GPRO
$116M
| $11.8M | 0.03% |
1,381,995
+559,509
| +68% | +$4.96M |
|
542
Delek US
DK
$4.38B
| $11.8M | 0.03% |
+554,593
| New | +$10.1M |
|
543
Tronox
TROX
$888M
| $11.7M | 0.03% |
592,453
-405,712
| -41% | -$8.8M |
|
|
GES
544
DELISTED
Guess Inc
GES
| $11.7M | 0.03% |
536,410
+468,110
| +685% | +$10.1M |
|
545
Jacobs Solutions
J
$17.6B
| $11.7M | 0.03% |
102,746
+77,063
| +300% | +$8.27M |
|
546
Floor & Decor
FND
$5.78B
| $11.7M | 0.03% |
144,479
+72,774
| +101% | +$7.37M |
|
547
HealthEquity
HQY
$8.81B
| $11.6M | 0.03% |
172,176
-423,381
| -71% | -$22.9M |
|
548
The GEO Group
GEO
$4.31B
| $11.6M | 0.03% |
1,748,527
+706,092
| +68% | +$4.62M |
|
549
Bilibili
BILI
$7.14B
| $11.5M | 0.03% |
449,819
-311,811
| -41% | -$10M |
|
|
HOLX
550
DELISTED
Hologic
HOLX
| $11.5M | 0.03% |
149,657
+80,052
| +115% | +$5.76M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.